Maxime L.
- Country
- France
- Department
- CIC-P
Research Overview
- A Phase II double-blind multi-center, placebo-controlled trial, to assess the efficacy and safety of alpelisib (BYL719) in pediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP)
- A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persistent infection with HPV Types 16, 18, 31, 33, 45, 52, or 58 in adult males, 20 to 45 years of age
Data & Insights
Has run more than one trial at 4 of 35 partner sites.
Specializations
Neurological Disorders
The investigator specializes in studying therapeutic approaches for Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP), a rare neurological condition affecting brain development.
- Adaptive Behavior Assessment
- Developmental Disorders
- Brain Malformation Syndromes
Their research extends to evaluating novel therapeutic interventions targeting developmental brain disorders and their associated symptoms.
Preventive Medicine
The investigator focuses on preventive strategies against human papillomavirus (HPV) infections, particularly studying vaccination efficacy in adult male populations.
- Oral HPV Prevention
- Vaccine Immunogenicity
- Adult Male Population Studies
Their work encompasses the evaluation of multi-valent vaccines and their effectiveness in preventing persistent viral infections.
Clinical Therapeutics
The investigator conducts research on targeted therapeutic interventions across different age groups, from pediatric to adult populations.
- Age-Specific Treatment Protocols
- Safety Assessment Methods
- Long-term Treatment Outcomes
Their research includes evaluation of therapeutic efficacy and safety profiles in diverse patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.